PharmaNews.eu
  • Home
  • Business
  • R&D
  • EC
  • EMA
  • Events
  • Open Calls

Bayer

The Bayer GroupThe Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at www.bayerscheringpharma.de.

Bayer RSS Channel

Filters
List of articles in category Bayer
Title Published Date
Bayer completes acquisition of Steigerwald 01 July 2013
Bayer HealthCare joins forces with Stroke Alliance for Europe 07 May 2013
Bayer HealthCare to broaden strategic alliance with German Cancer Research Center 11 April 2013
Bayer supports innovative drug discovery in Europe 11 February 2013
Bayer supports pharmaceutical research in Europe 28 November 2012
Bayer's Xarelto® (Rivaroxaban) approved for the treatment of pulmonary embolism (PE) and the prevention of recurrent deep vein thrombosis (DVT) and PE 19 November 2012
Latest Xarelto® (Rivaroxaban) data to be presented at ESC Congress 2012 20 August 2012
UK's NICE recommends Bayer's Xarelto® 25 July 2012
Bayer enters into strategic partnership with Covance 04 June 2012
Bayer's Xarelto® (Rivaroxaban) Submitted for EU Marketing Authorisation for Secondary Prevention after an Acute Coronary Syndrome 27 December 2011
Results of ROCKET AF Study of Bayer’s Xarelto® (Rivaroxaban) 10 August 2011
Bayer continues positive momentum 01 August 2011
Bayer advances research in the area of pulmonary hypertension 01 July 2011
VEGF Trap-Eye Submitted for EU Marketing Authorization 09 June 2011
Major Subgroup Analysis Shows Bayer's Rivaroxaban is Highly Effective in the Prevention of Recurrent Strokes 30 May 2011
Bayer off to a successful start to 2011 02 May 2011
Bayer affirms the positive benefit-risk profile of its drospirenone- containing oral contraceptives 26 April 2011
Bayer and Regeneron Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 08 April 2011
OncoTrack: A new International consortium launches project in the area of genomic cancer diagnostics 13 March 2011
Bayer and Onyx Initiate Phase III Trial of Nexavar® in Combination with Chemotherapy 24 February 2011

Page 3 of 5

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • End
  1. You are here:  
  2. Home
  3. Bayer

About

  • Home
  • Terms and Conditions
  • Contact

Advertise

Top News Channels

  • Business
  • Research
  • EMA
  • Events

Follow us

Didn't we got you connected? If not, please note the following magic buttons:

  • Facebook
  • Twitter
  • RSS 2.0
  • Atom 1.0

Newsletter

Stay updated on the latest Pharma News. Subscribe now, it's free!

Copyright © 2025 PharmaNews.eu. All Rights Reserved.